These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4233253)

  • 1. [Immunization against trachoma].
    Grayston JT
    Bol Oficina Sanit Panam; 1968 Sep; 65(3):220-37. PubMed ID: 4233253
    [No Abstract]   [Full Text] [Related]  

  • 2. Attempted immunization against trachoma infection in baboons.
    Provost PJ; Vickers JH
    Am J Vet Res; 1972 Mar; 33(3):599-605. PubMed ID: 4622558
    [No Abstract]   [Full Text] [Related]  

  • 3. Local antibodies to trachoma agent.
    Zakay-Rones Z; Levy R; Maythar B
    Isr J Med Sci; 1972; 8(8):1130-3. PubMed ID: 4630592
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia.
    Nichols RL; Bell SD; Murray ES; Haddad NA; Bobb AA
    Am J Trop Med Hyg; 1966 Jul; 15(4):639-47. PubMed ID: 5941182
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis and immunology of trachoma.
    Grayston JT; Gale JL; Yeh LJ; Yang CY
    Trans Assoc Am Physicians; 1972; 85():203-11. PubMed ID: 4573632
    [No Abstract]   [Full Text] [Related]  

  • 6. Some aspects of immunity in trachoma.
    Bietti GB; Soldari M; Isetta AM; Intini C; Ghione M
    Isr J Med Sci; 1972; 8(8):1124-9. PubMed ID: 4647758
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New observations on oral vaccination against dysentery.
    Rauss K; Kétyi I; Máté J; Kneffel P; Ambó G; Maróczi J; Pusztai S; Joó I; Szendrei L
    Acta Microbiol Acad Sci Hung; 1969; 16(2):159-69. PubMed ID: 5393007
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunization of mice against toxic doses of homologous elementary bodies of trachoma.
    BELL SD; SNYDER JC; MURRAY ES
    Science; 1959 Sep; 130(3376):626-7. PubMed ID: 13798522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathological immune phenomena in virus diseases].
    Lehmann-Grube F
    Med Klin; 1970 Aug; 65(34):1472-6. PubMed ID: 4329530
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus.
    Kass E; Schlom J; Thompson J; Guadagni F; Graziano P; Greiner JW
    Cancer Res; 1999 Feb; 59(3):676-83. PubMed ID: 9973217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells.
    Collier LH; Blyth WA
    J Hyg (Lond); 1966 Dec; 64(4):513-28. PubMed ID: 4959126
    [No Abstract]   [Full Text] [Related]  

  • 13. Local and humoral chlamydial antibodies in trachoma patients of different age groups.
    Maythar B; Zakay-Rones Z
    Invest Ophthalmol; 1972 Aug; 11(8):651-4. PubMed ID: 4625573
    [No Abstract]   [Full Text] [Related]  

  • 14. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Darkfield agglutination of fluorocarbon-treated trachoma virus by serums of trachoma patients and immunized rabbits.
    BERNKOPF H; NISHMI M; MAYTHAR B; FEITELBERG I
    J Infect Dis; 1960; 106():83-6. PubMed ID: 13799801
    [No Abstract]   [Full Text] [Related]  

  • 16. [Trachoma virus and trachoma vaccination].
    REIMOLD G
    Dtsch Med Wochenschr; 1960 Nov; 85():2077. PubMed ID: 13740563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Viruses and heredity. Importance of their relations in the ophthalmological field, with special reference to trachoma from the genetic viewpoint].
    Bietti GB; Gedda L; Vozza R; Brenci G
    Acta Genet Med Gemellol (Roma); 1965 Oct; 14(4):337-52. PubMed ID: 5882605
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A retrospective study on the immunologic aspects of parasitic infections].
    Taliaferro WH
    Bol Oficina Sanit Panam; 1969 Feb; 66(2):121-46. PubMed ID: 4238614
    [No Abstract]   [Full Text] [Related]  

  • 20. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.